Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors

LOS ANGELES, March 11, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Aquestive Therapeutics, Inc., (“Aquestive” or the "Company") (NASDAQ: AQST) investors off a class action on behalf of investors that bought securities between June 16, 2025 and January 8, 2026, inclusive (the “Class Period”). Aquestive investors have until May 4, 2026 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss the ...